Kent and Medway
Joint Medicines Formulary
NHS Kent and Medway
  • Therapeutic Sections
    • Gastro-intestinal system
    • Cardiovascular system
    • Respiratory system
    • Nervous system
    • Infection
    • Endocrine system
    • Genito-urinary system
    • Immune system and malignant disease
    • Blood and Nutrition
    • Musculoskeletal system
    • Eye
    • Ear, nose and oropharynx
    • Skin
    • Vaccines
    • Anaesthesia
    • Preparations used in diagnosis
    • Emergency treatment of poisoning
    • Wound Management
    • Over the Counter Items
  • K&M ICB Guidelines
    • KMICB - Antimicrobial Guidelines
    • KMICB - Gastro-intestinal system
    • KMICB - Cardiovascular system
    • KMICB - Respiratory system
    • KMICB - Nervous system
    • KMICB - Endocrine system
    • KMICB - Genito-urinary system
    • KMICB - Immune system and malignant disease
    • KMICB - Blood and nutrition
    • KMICB - Musculoskeletal system
    • KMICB - Eye
    • KMICB - Ear, nose and oropharynx
    • KMICB - Skin
    • KMICB - Vaccines
    • KMICB - Shared Care Guidance
    • KMICB - Palliative Care
    • KMICB - Miscellaneous
    • KMICB - Communications
    • KMICB - Stoma Products
    • KMICB - Continence products
    • KMICB - Care Home Resources
    • High Cost Drugs Manual
    • SERMOG Recommendations
  • Maidstone and Tunbridge Wells NHS Trust (MTW)
    • MTW - Antimicrobial Guidelines
    • MTW - Electrolyte Guidelines
    • MTW - Thromboembolism Guidelines
    • MTW - Miscellaneous Guidelines
    • MTW - Drug Request Forms & Procedures
  • Dartford and Gravesham NHS Trust (DGT)
  • Medway Foundation Trust NHS Trust (MFT)
  • East Kent Primary Care and East Kent Hospitals University NHS Foundation Trust (EKHUFT)
    • EK - Local recommendations (Cardiovascular)
    • EK - Local recommendations (Eye)
    • EK - Local recommendations (Gastro-intestinal)
    • EK - Local recommendations (Nose)
    • EK - Local recommendations (Nutrition)
    • EK - Local recommendations (Oropharynx)
    • EK - Local recommendations (Respiratory)
    • EK - Local recommendations (Blood)
    • EK - Local recommendations (Nervous system)
    • EK - Local recommendations (Infection)
    • EK - Local recommendations (Endocrine)
    • EK - Local recommendations (Genito-urinary)
    • EK - Local recommendations (Malignant disease)
    • EK - Local recommendations (Musculoskeletal system)
    • EK - Local recommendations (Skin)
    • EK - Local recommendations (Vaccines)
    • EK - Prescribing Recommendations
  • Using the Formulary
  • Therapeutic Sections
  • K&M ICB Guidelines
  • K&M ICB Medicine Applications
  • K&M ICB Primary Care Newsletters
  • K&M ICB Integrated Medicines Optimisation Commitee (IMOC) Minutes
  • Maidstone and Tunbridge Wells NHS Trust (MTW)
  • Dartford and Gravesham NHS Trust (DGT)
  • Medway Foundation Trust NHS Trust (MFT)
  • East Kent Primary Care and East Kent Hospitals University NHS Foundation Trust (EKHUFT)
  • Intravenous Immunoglobulin (IVIG)
  • Drug Index
  • Search

Drug Index

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

V

  • Vadadustat

    Dartford and Gravesham NHS Trust ONLY East Kent Hospital University Foundation Trust ONLY High Cost Drug Go to NICE for more information and guidance. Go to the EMC website for more information and guidance. Go to the Blueteq website for more information and guidance.
  • Valaciclovir

    Go to the EMC website for more information and guidance.
  • Valganciclovir

    Go to the EMC website for more information and guidance.
  • Valproic acid

    Go to NICE for more information and guidance. Go to the EMC website for more information and guidance.
  • Valsartan

    Go to the EMC website for more information and guidance.
  • Vancomycin

    Go to the EMC website for more information and guidance.
  • Vardenafil

    Go to the EMC website for more information and guidance.
  • Varenicline

    Go to NICE for more information and guidance. Go to the EMC website for more information and guidance.
  • Varicella-zoster vaccine

    Go to the EMC website for more information and guidance.
  • Vecuronium

    Go to the EMC website for more information and guidance.
  • Vedolizumab

    High Cost Drug Go to NICE for more information and guidance. Go to the EMC website for more information and guidance. Go to the Blueteq website for more information and guidance.
  • Venlafaxine

    Go to the EMC website for more information and guidance.
  • Verapamil

    Go to the EMC website for more information and guidance.
  • Verteporfin

    Ophthalmology Initiation High Cost Drug Go to NICE for more information and guidance. Go to the EMC website for more information and guidance. Go to the Blueteq website for more information and guidance.
  • Vibegron

    Go to NICE for more information and guidance. Go to the EMC website for more information and guidance.
  • Vigabatrin

    Go to NICE for more information and guidance. Go to the EMC website for more information and guidance.
  • Vitamin A

    Unlicenced Drug Go to the EMC website for more information and guidance.
  • Vitamin A and D

    Go to the EMC website for more information and guidance.
  • Vitamin B compound strong

    Go to the EMC website for more information and guidance.
  • Vitamin B&C

    Go to the EMC website for more information and guidance.
  • Voclosporin

    East Kent Hospital University Foundation Trust ONLY High Cost Drug Go to NICE for more information and guidance. Go to the EMC website for more information and guidance. Go to the Blueteq website for more information and guidance.
  • Volumatic

  • Voriconazole

    High Cost Drug Go to the EMC website for more information and guidance.
  • Voriconazole

    Ophthalmology Initiation Unlicenced Use East Kent Hospital University Foundation Trust ONLY Maidstone and Tunbridge Wells NHS Trust ONLY Go to the EMC website for more information and guidance.
  • Vortioxetine

    Go to NICE for more information and guidance. Go to the EMC website for more information and guidance.
  • On Formulary Preferred
  • On Formulary Second Line
  • On Formulary Third Line
  • Specialist Initiation
  • Secondary Care Only
  • Not Approved for Formulary

Online Formulary by M.O.M. Systems

NICE guidance is available from https://www.nice.org.uk/guidance All rights reserved. Subject to Notice of rights.
NICE guidance is prepared for the National Health Service in England. All NICE guidance is subject to regular review and may be updated or withdrawn. NICE accepts no responsibility for the use of its content in this product/publication.

© Copyright 2026